PHXM
PHAXIAM Therapeutics S.A.
NASDAQ: PHXM · HEALTHCARE · BIOTECHNOLOGY
$3.10
+0.00% today
Updated 2026-05-01
Market cap
$28.90M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-39.05
Dividend yield
—
52W range
$0 – $0
Volume
—
PHAXIAM Therapeutics S.A. (PHXM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.84M | $1.80M | $4.37M | $10.78M | $19.72M | $3.36M | — | $5.28M | $0.00 | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | — | — | -2.0% | +142.5% | +146.6% | +83.0% | -82.9% | -100.0% | — | -100.0% | — | — | — |
| Cost of revenue | $286051.00 | $315867.00 | $312577.00 | $261160.00 | $4.37M | $10.78M | $19.72M | $530000.00 | $797000.00 | $4.22M | $4.99M | $5.38M | $2.91M | $1.61M |
| Gross profit | $-286000.00 | $-316000.00 | $-313000.00 | $-261000.00 | — | — | — | $-25.46M | $-33.47M | $1.07M | $-4.99M | $-5.38M | $-2.91M | $-1.61M |
| Gross margin | — | — | -17.0% | -14.5% | 0.0% | 0.0% | 0.0% | -756.9% | — | 20.2% | — | — | — | — |
| R&D | $3.76M | $3.56M | $1.62M | $2.50M | $2.24M | $10.53M | $19.53M | $25.46M | $33.47M | $52.19M | $53.27M | $40.22M | $15.91M | $9.84M |
| SG&A | — | — | $3.30M | $3.55M | $4.36M | $7.62M | $6.66M | $8.79M | $14.60M | $17.16M | $14.97M | $15.10M | $13.89M | — |
| Operating income | $-6.48M | $-6.71M | $-6.97M | $-7.08M | $-8.95M | $-18.43M | $-26.21M | $-30.89M | $-43.62M | $5.28M | $-72.55M | $-56.52M | $-32.08M | $-25.42M |
| Operating margin | — | — | -379.3% | -393.2% | -204.8% | -171.0% | -132.9% | -918.2% | — | 100.0% | — | — | — | — |
| EBITDA | $-6.20M | $-6.40M | $-6.66M | $-8.02M | $-10.72M | $-15.25M | $-25.78M | $-33.72M | $-47.27M | $5.28M | $-67.94M | $-47.45M | $-22.69M | $-23.81M |
| EBITDA margin | — | — | -362.4% | -445.0% | -245.5% | -141.5% | -130.8% | -1002.5% | — | 100.0% | — | — | — | — |
| EBIT | $-6.48M | $-6.71M | $-6.95M | $-8.28M | $-10.97M | $-15.54M | $-26.21M | $-34.25M | $-38.21M | $8.23M | $-72.93M | $-52.83M | $-25.60M | $-25.42M |
| Interest expense | $68876.00 | $224622.00 | $9382.00 | $4656.00 | $6801.00 | $5000.00 | $4000.00 | $3.18M | $9000.00 | $1.53M | $5.35M | $2.14M | $1.36M | $196000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.84M | $-5.91M | $-2.17M | $-8.14M | $-8.86M | $-15.01M | $-21.91M | $-33.53M | $-38.22M | $-62.66M | $-73.30M | $-53.80M | $-227000.00 | $-23.49M |
| Net income growth (YoY) | — | -22.1% | +63.2% | -275.0% | -8.8% | -69.4% | -46.0% | -53.0% | -14.0% | -63.9% | -17.0% | +26.6% | +99.6% | -10247.1% |
| Profit margin | — | — | -118.2% | -452.0% | -202.8% | -139.3% | -111.1% | -996.7% | — | -1186.0% | — | — | — | — |